
Erica S Y Lin
Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2861 |
| Total Applications | 1103 |
| Issued Applications | 882 |
| Pending Applications | 99 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13013913
[patent_doc_number] => 10030064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Mammalian cell culture processes for protein production
[patent_app_type] => utility
[patent_app_number] => 15/366281
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 21
[patent_no_of_words] => 21733
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366281 | Mammalian cell culture processes for protein production | Nov 30, 2016 | Issued |
Array
(
[id] => 11619749
[patent_doc_number] => 20170129936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'MAMMALIAN CELL CULTURE PROCESSES FOR PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 15/366218
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 23237
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366218 | Mammalian cell culture processes for protein production | Nov 30, 2016 | Issued |
Array
(
[id] => 17378139
[patent_doc_number] => 11236136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Methods of producing glycosylated proteins
[patent_app_type] => utility
[patent_app_number] => 15/779839
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21360
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779839
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779839 | Methods of producing glycosylated proteins | Nov 29, 2016 | Issued |
Array
(
[id] => 13590781
[patent_doc_number] => 20180346939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => GENETICALLY MODIFIED YEASTS AND FERMENTATION PROCESSES USING GENETICALLY MODIFIED YEASTS
[patent_app_type] => utility
[patent_app_number] => 15/778873
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778873
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778873 | Genetically modified yeasts and fermentation processes using genetically modified yeasts | Nov 21, 2016 | Issued |
Array
(
[id] => 16230792
[patent_doc_number] => 10738332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Genetically modified yeasts and fermentation processes using genetically modified yeasts
[patent_app_type] => utility
[patent_app_number] => 15/778881
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8400
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778881
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778881 | Genetically modified yeasts and fermentation processes using genetically modified yeasts | Nov 21, 2016 | Issued |
Array
(
[id] => 11542828
[patent_doc_number] => 20170096654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'Subtilase Variants'
[patent_app_type] => utility
[patent_app_number] => 15/355435
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13298
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15355435
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/355435 | Subtilase variants | Nov 17, 2016 | Issued |
Array
(
[id] => 11649557
[patent_doc_number] => 20170145459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'Cell-Based Production of Nonulosonates'
[patent_app_type] => utility
[patent_app_number] => 15/354603
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13455
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354603
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/354603 | Cell-based production of nonulosonates | Nov 16, 2016 | Issued |
Array
(
[id] => 11706248
[patent_doc_number] => 20170174745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS'
[patent_app_type] => utility
[patent_app_number] => 15/355007
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 41885
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15355007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/355007 | Multivalent heteromultimer scaffold design and constructs | Nov 16, 2016 | Issued |
Array
(
[id] => 15678467
[patent_doc_number] => 20200093897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => METHOD FOR DETECTING WHETHER GLUCOSE METABOLISM IS ABNORMAL, AND PREVENTION AND TREATMENT THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/349286
[patent_app_country] => US
[patent_app_date] => 2016-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349286 | Method for detecting whether glucose metabolism is abnormal, and prevention and treatment therefor | Nov 13, 2016 | Issued |
Array
(
[id] => 14485177
[patent_doc_number] => 10329356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Fungal-specific metalloproteases and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/349928
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 39
[patent_no_of_words] => 35474
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349928
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349928 | Fungal-specific metalloproteases and uses thereof | Nov 10, 2016 | Issued |
Array
(
[id] => 11492622
[patent_doc_number] => 20170066807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'LIPOCALIN MUTEINS WITH BINDING-AFFINITY FOR GLYPICAN-3 (GPC-3) AND USE OF LIPOCALIN MUTEINS FOR TARGET-SPECIFIC DELIVERY TO CELLS EXPRESSING GPC-3'
[patent_app_type] => utility
[patent_app_number] => 15/341793
[patent_app_country] => US
[patent_app_date] => 2016-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23599
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15341793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/341793 | LIPOCALIN MUTEINS WITH BINDING-AFFINITY FOR GLYPICAN-3 (GPC-3) AND USE OF LIPOCALIN MUTEINS FOR TARGET-SPECIFIC DELIVERY TO CELLS EXPRESSING GPC-3 | Nov 1, 2016 | Abandoned |
Array
(
[id] => 16141449
[patent_doc_number] => 10703786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Methods and compositions for improving glucose metabolism
[patent_app_type] => utility
[patent_app_number] => 15/771980
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17031
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771980
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/771980 | Methods and compositions for improving glucose metabolism | Oct 27, 2016 | Issued |
Array
(
[id] => 13840561
[patent_doc_number] => 20190023765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => METHOD FOR PRODUCING ERYTHROCYTE PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/768715
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768715
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/768715 | Method for producing erythrocyte proteins | Oct 13, 2016 | Issued |
Array
(
[id] => 13916641
[patent_doc_number] => 10202428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Compositions and methods for the delivery of oxygen
[patent_app_type] => utility
[patent_app_number] => 15/292012
[patent_app_country] => US
[patent_app_date] => 2016-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 32855
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15292012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/292012 | Compositions and methods for the delivery of oxygen | Oct 11, 2016 | Issued |
Array
(
[id] => 11943560
[patent_doc_number] => 20170247709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'EUKARYOTIC ORGANISMS AND METHODS FOR INCREASING THE AVAILABILITY OF CYTOSOLIC ACETYL-COA, AND FOR PRODUCING 1,3-BUTANEDIOL'
[patent_app_type] => utility
[patent_app_number] => 15/290895
[patent_app_country] => US
[patent_app_date] => 2016-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 115153
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15290895
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/290895 | EUKARYOTIC ORGANISMS AND METHODS FOR INCREASING THE AVAILABILITY OF CYTOSOLIC ACETYL-COA, AND FOR PRODUCING 1,3-BUTANEDIOL | Oct 10, 2016 | Abandoned |
Array
(
[id] => 14031811
[patent_doc_number] => 10227645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Alpha-hemolysin variants
[patent_app_type] => utility
[patent_app_number] => 15/274770
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 30
[patent_no_of_words] => 16002
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15274770
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/274770 | Alpha-hemolysin variants | Sep 22, 2016 | Issued |
Array
(
[id] => 16230794
[patent_doc_number] => 10738334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Cells having reduced BCAT1
[patent_app_type] => utility
[patent_app_number] => 15/762345
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 41175
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762345 | Cells having reduced BCAT1 | Sep 21, 2016 | Issued |
Array
(
[id] => 11365319
[patent_doc_number] => 20170003301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'METHOD TO PREDICT RESPONSE TO PHARMACOLOGICAL CHAPERONE TREATMENT OF DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/268662
[patent_app_country] => US
[patent_app_date] => 2016-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 14024
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268662
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/268662 | METHOD TO PREDICT RESPONSE TO PHARMACOLOGICAL CHAPERONE TREATMENT OF DISEASES | Sep 18, 2016 | Abandoned |
Array
(
[id] => 16091131
[patent_doc_number] => 20200199552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => VARIANT CAS9 POLYPEPTIDES COMPRISING INTERNAL INSERTIONS
[patent_app_type] => utility
[patent_app_number] => 15/751432
[patent_app_country] => US
[patent_app_date] => 2016-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751432
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751432 | Variant Cas9 polypeptides comprising internal insertions | Sep 14, 2016 | Issued |
Array
(
[id] => 13037935
[patent_doc_number] => 10041092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Methods for genomic integration
[patent_app_type] => utility
[patent_app_number] => 15/261727
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 36
[patent_no_of_words] => 38773
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15261727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/261727 | Methods for genomic integration | Sep 8, 2016 | Issued |